Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Cash from Operations (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Cash from Operations for 3 consecutive years, with 3844000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations rose 23.15% year-over-year to 3844000.0, compared with a TTM value of 14198000.0 through Sep 2025, up 10.13%, and an annual FY2024 reading of 16007000.0, down 55.63% over the prior year.
  • Cash from Operations was 3844000.0 for Q3 2025 at SeaStar Medical Holding, down from 3007000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1337000.0 in Q3 2023 and bottomed at 5002000.0 in Q3 2024.
  • Average Cash from Operations over 3 years is 3254272.73, with a median of 3007000.0 recorded in 2025.
  • The sharpest move saw Cash from Operations crashed 274.12% in 2024, then grew 23.91% in 2025.
  • Year by year, Cash from Operations stood at 4485000.0 in 2023, then decreased by 4.64% to 4693000.0 in 2024, then increased by 18.09% to 3844000.0 in 2025.
  • Business Quant data shows Cash from Operations for ICU at 3844000.0 in Q3 2025, 3007000.0 in Q2 2025, and 2654000.0 in Q1 2025.